Abbara, A, Jayasena, C N, Christopoulos, G et al. (2015). Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy. J Clin Endocr Metab 100, 3322–3331.
Abbara, A, Clarke, S, Islam, R et al. (2017). A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a phase 2 randomized controlled trial. Hum Reprod 32, 1915–1924
Abbara, A, Islam, R, Clarke, S A et al. (2018). Clinical parameters of ovarian hyperstimulation syndrome (OHSS) following different hormonal triggers of oocyte maturation in IVF treatment. Clin Endocr 88, 920–927.
Abs, R, Verhelst, J, Maeyaert, J et al. (2000). Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocr Metab 85, 2215–2222.
Ahmed, M I, Duleba, A J, El Shahat, O, Ibrahim, M E & Salem, A. (2008). Naltrexone treatment in clomiphene-resistant women with polycystic ovary syndrome. Human Reprod 23, 2564–2569.
Antunes, J L, Carmel, P W, Housepian, E M & Ferin, M. (1978). Luteinizing hormone-releasing hormone in human pituitary blood. J Neurosurg 49, 382–386.
Azziz, R, Marin, C, Hoq, L, Badamgarav, E & Song, P. (2005). Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocr Metab 90, 4650–4658.
Balasubramanian, R, Dwyer, A, Seminara, S B, Pitteloud, N, Kaiser, U B & Crowley, W F Jr. (2010). Human GnRH deficiency: a unique disease model to unravel the ontogeny of GnRH neurons. Neuroendocr 92, 81–99.
Barbieri, R L. (2014). The endocrinology of the menstrual cycle. Methods Mol Biol 1154, 145–169.
Belchetz, P E, Plant, T M, Nakai, Y, Keogh, E J & Knobil, E. (1978). Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 202, 631–633.
Besser, G M & Thorner, M O. (2002). Comprehensive Clinical Endocrinology, 3rd Edition (St. Louis, MO: Mosby).
Bianco, S D & Kaiser, U B. (2009). The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocr 5, 569–576.
Boehm, U, Bouloux, P-M, Dattani, M T et al. (2015). European Consensus Statement on congenital hypogonadotropic hypogonadism – pathogenesis, diagnosis and treatment. Nat Revs Endocr 11, 547–564.
Boron, W F & Boulpaep, E L. (2009). Medical Physiology, 2nd Edition (Philadelphia, PA: Elsevier Saunders).
Borsay, B A, Skrapits, K, Herczeg, L et al. (2014). Hypophysiotropic gonadotropin-releasing hormone projections are exposed to dense plexuses of kisspeptin, neurokinin B and substance P immunoreactive fibers in the human: a study on tissues from postmenopausal women. Neuroendocr 100, 141–152.
Boyar, R, Katz, J, Finkelstein, J W et al. (1974). Immaturity of 24-hour luteinizing hormone secretory pattern. New Engl J Med 291, 861–865.
Brennan, M J. (2013). The effect of opioid therapy on endocrine function. Am J Med 126, S12–S18.
Brown, R E, Imran, S A, Ur, E & Wilkinson, M. (2008). KiSS-1 mRNA in adipose tissue is regulated by sex hormones and food intake. Mol Cell Endocr 281, 64–72.
Cockwell, H, Wilkinson, DA, Bouzayen, R, Imran, S A, Brown, R & Wilkinson, M. (2013). KISS1 expression in human female adipose tissue. Arch Gynecol Obstet 287, 143–147.
Compton, W M, Jones, C M & Baldwin, G T. (2016). Relationship between nonmedical prescription-opioid use and heroin use. New Engl J Med 374, 154–163.
Couzinet, B, Young, J, Brailly, S, Chanson, P & Schaison, G. (1995). Even after priming with ovarian steroids or pulsatile gonadotrophin releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea. J Clin Endocr Metab 80, 2102–2107.
Daniell, H W. (2008). Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 9, 28–36.
de Kretser, D M & O’Donnell, L. (2013). Endocrinology of the Male Reproductive System. www.endotext.org
Delvigne, A & Rozenberg, S. (2002). Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8, 559–577.
Dhillo, W S, Chaudhri, O B, Thompson, E L et al. (2007). Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocr Metab 92, 3958–3966.
Dudas, B & Merchenthaler, I. (2001). Catecholaminergic axons innervate LH-releasing hormone immunoreactive neurons of the human diencephalon. J Clin Endocr Metab 86, 5620–5626.
Dudas, B & Merchenthaler, I. (2004). Close anatomical associations between β-endorphin and luteinizing hormone-releasing hormone neuronal systems in the human diencephalon. Neurosci 124, 221–229.
Dudas, B & Merchenthaler, I. (2006). Three-dimensional representation of the neurotransmitter systems of the human hypothalamus: inputs of the gonadotrophin hormone-releasing hormone neuronal system. J Neuroendocr 18, 79–95.
Engel, J B & Schally, A V. (2007). Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Practice Endocr Metab 3, 157–167.
Eyvazzadeh, A D, Pennington, K P, Pop-Busui, R, Sowers, M, Zubieta, J-K & Smith, Y R. (2009). The role of the endogenous opioid system in polycystic ovary syndrome. Fertil Steril 92, 1–12.
Ferin, M, Wehrenberg, W B, Lam, N Y, Alston, E J & Vande Wiele, R L. (1982). Effects and site of action of morphine on gonadotropin secretion in the female rhesus monkey. Endocr 111, 1652–1656.
Filicori, M, Santoro, N, Merriam, G R & Crowley, W F Jr. (1986). Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocr Metab 62, 1136–1144.
Fraser, H M. (1993). GnRH analogues for contraception. Brit Med Bull 49, 62–72.
Fruzzetti, F, Bersi, C, Parrini, D, Ricci, C & Genazzani, AR. (2002). Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertil Steril 77, 936–944.
Genazzani, AD, Gastaldi, M, Petraglia, F et al. (1995). Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. Human Reprod 10, 2868–2871.
Giusti, M, Delitala, G, Marini, G et al. (1992). The effect of a met-enkephalin analogue on growth hormone, prolactin, gonadotropins, cortisol and thyroid stimulating hormone in healthy elderly men. Acta Endocr 127, 205–209.
Graves, G R, Kennedy, T G, Weick, R F & Casper, R F. (1993). The effect of nalmefene on pulsatile secretion of luteinizing hormone and prolactin in men. Hum Reprod 8, 1598–1603.
Grumbach, M M. (2002). The neuroendocrinology of human puberty revisited. Horm Res 57 (Suppl2), 2–14.
Hall, J E. (2014). Neuroendocrine control of the menstrual cycle. Yen and Jaffe’s Reproductive Endocrinology, 7th Edition. Strauss, J F & Barbieri, R L, Eds. (Philadelphia, PA: Elsevier), 141–156.
Harihar, S, Pounds, K M, Iwakuma, T, Seidah, N G & Welch, D R. (2015). Furin is the major proprotein convertase required for KISS1-to-kisspeptin processing. PLoS One 9, e84958.
Herbison, A E. (2015). Physiology of the adult gonadotropin-releasing hormone neuronal network. Knobil and Neill’s Physiology of Reproduction, 4th Edition. Plant, T M & Zeleznik, A J, Eds. (New York: Elsevier), 399–467.
Herbison, A E. (2016). Control of puberty onset and fertility by gonadotropin-releasing hormone neurons. Nat Rev Endocr 12, 452–466.
Hrabovszky, E, Ciofi, P, Vida, B et al. (2010). The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Europ J Neurosci 31, 1984–1998.
Hrabovszky, E, Molnár, C S, Nagy, R et al. (2012). Glutamatergic and GABAergic innervation of human gonadotropin-releasing hormone-I neurons. Endocr 153, 2766–2776.
Hrabovszky, E & Liposits, Z. (2013). Afferent neuronal control of type-1 gonadotropin releasing hormone neurons in the human. Fronts Endocr 4, 1–19.
Hrabovszky, E. (2014). Neuroanatomy of the human hypothalamic kisspeptin system. Neuroendocr 99, 33–48.
Jayasena, C N, Nijher, G M K, Chaudhri, O B et al. (2009). Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocr Metab 94, 4315–4323.
Jayasena, C N, Comninos, A N, Veldhuis, J D et al. (2013). A single injection of kisspeptin-54 temporarily increases luteinizing hormone pulsatility in healthy women. Clin Endocr 79, 558–563.
Jayasena, C N, Abbara, A, Veldhuis, J D et al. (2014). Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of kisspeptin-54. J Clin Endocr Metab 99, E953–E961.
Jayasena, C N, Abbara, A, Comninos, A N et al. (2014a). Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest 124, 3667–3677.
Jayasena, C N, Abbara, A, Narayanaswamy, S et al. (2015). Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men. Hum Reprod 30, 1934–1941.
Kapen, S, Boyar, R M, Finkelstein, J W, Hellman, L & Weitzman, E D. (1974). Effect of sleep-wake cycle reversal on luteinizing hormone secretory pattern in puberty. J Clin Endocr Metab 39, 293–299.
Katz, N & Mazer, N A. (2009). The impact of opioids on the endocrine system. Clin J Pain 25, 170–175.
Khoury, S A, Reame, N E, Kelch, R P & Marshall, J C. (1987). Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an α2-adrenergic agonist. J Clin Endocr Metab 64, 755–762.
Knight, P J, Satchell, L & Glister, C. (2012). Intra-ovarian roles of activins and inhibins. Mol Cell Endocr 359,53–65.
Koons, A L, Rayl Greenberg, M, Cannon, R D & Beauchamp, G A. (2018). Women and the experience of pain and opioid use disorder: a literature-based commentary. Clin Therap 40, 190–196.
Krsmanovic, L Z, Hu, L, Leung, P-K, Feng, H & Catt, K J. (2009). The hypothalamic GnRH pulse generator: multiple regulatory mechanisms. Trends Endocr Metab 20, 402–408.
Lehman, M N, Coolen, L M & Goodman, R L. (2010). Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocr 151, 3479–3489.
Liu, J H, Patel, B & Collins, G. (2016). Central causes of amenorrhea. www.endotext.org
McCarthy, M M. (2013). A piece in the puzzle of puberty. Nat Neurosci 16, 251–253.
Meczekalski, B, Podfigurna-Stopa, A, Warenik-szymankiewicz, A & Genazzani, A R. (2008). Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol Endocr 24, 4–11.
Messager, S, Chatzidaki, E E, Ma, D et al. (2005). Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Nat Acad Sci USA 102, 1761–1766.
Messinis, I E, Messini, C I, & Dafopoulos, K. (2014). Novel aspects of the endocrinology of the menstrual cycle. Reprod Biomed Online 28, 714–722.
Millar, R P, Sonigo, C, Anderson, R A et al. (2017). Hypothalamic–pituitary–ovarian axis reactivation by kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea. J Endocr Soc 1, 1362–1371.
Moenter, S M. (2015). Leap of faith: does serum luteinizing hormone always accurately reflect central reproductive neuroendocrine activity? Neuroendocr 102, 256–266.
Narayanaswamy, S, Jayasena, C N, Ng, N et al. (2015). Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels. Clin Endocr 84, 939–945.
Oakley, A E, Clifton, D K & Steiner, R A. (2009). Kisspeptin signaling in the brain. Endocr Rev 30, 713–743.
Padmanabhan, V. (2009). Polycystic ovary syndrome – “a riddle wrapped in a mystery inside an enigma”. J Clin Endocr Metab 94, 1883–1885.
Peckys, D & Landwehrmeyer, G B. (1999). Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. Neurosci 88, 1093–1135.
Petraglia, F, Degli Uberti, E C, Trasforini, G et al. (1985). Dermorphin decreases plasma LH levels in human: evidence for a modulatory role of gonadal steroids. Peptides 6, 869–72.
Pinilla, L, Aguilar, E, Dieguez, C, Millar, R P & Tena-Sempere, M. (2012). Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Revs 92, 1235–1316.
Prague, J K & Dhillo, W S. (2015). Potential clinical use of kisspeptin. Neuroendocr 102, 238–245.
Prague, J K, Roberts, R E, Comninos, A N et al. (2017). Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 389, 1809–1820.
Rabin, D & McNeil, L W. (1980). Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females. J Clin Endocr Metab 51, 873–876.
Rance, N E. (2009). Menopause and the human hypothalamus: Evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback. Peptides 30, 111–122.
Rasmussen, D D, Gambacciani, M, Swartz, W, Tueros, V S & Yen, S S. (1989). Pulsatile gonadotropin-releasing hormone release from the human mediobasal hypothalamus in vitro: opiate receptor-mediated suppression. Neuroendocr 49, 150–156.
Reed, B J & Carr, B R. (2015). The normal menstrual cycle and the control of ovulation. www.endotext.org
Reid, R L, Hoff, J D, Yen, S S & Li, C H. (1981). Effects of exogenous beta-endorphin on pituitary hormone secretion and its disappearance in normal human subjects. J Clin Endocr Metab 52, 1179–1184.
Rhodin, A, Stridsberg, M & Gord, T. (2010). Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain 26, 373–380.
Roa, J, Aguilar, E, Dieguez, C, Pinilla, L & Tena-Sempere, M. (2008). New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Front Neuroendocr 29, 48–69.
Robertson, D M. (2012). Inhibins and activins in blood: predictors of female reproductive health? Mol Cell Endocr 34, 78–84.
Robertson, D M, Hale, G E, Jolley, D, Fraser, I S, Hughes, C L & Burger, H G. (2009). Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age. J Clin Endocr Metab 94, 138–144.
Roche, D J O & King, A C. (2015). Sex differences in acute hormonal and subjective response to naltrexone: the impact of menstrual cycle phase. Psychoneuroendocr 52, 59–71.
Rometo, A M & Rance, N E. (2008). Changes in prodynorphin gene expression and neuronal morphology in the hypothalamus of postmenopausal women. J Neuroendocr 20, 1376–1381.
Roozenburg, B J, van Dessel, H J H M, Evers, J L H & Bots, R S M. (1997). Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment. Human Reprod 12, 1720–1722.
Rossmanith, W G, Wirth, U, Sterzik, K & Yen, S S. (1989). The effects of prolonged opioidergic blockade on LH pulsatile secretion during the menstrual cycle. J Endocr Invest 12, 245–252.
Schmittner, J, Schroeder, J R, Epstein, D H & Preston, K L. (2005). Menstrual cycle length during methadone maintenance. Addiction 100, 829–836.
Semple, R K & Topaloglu, A K. (2010). Neurokinin B and its receptor in hypogonadotropic hypogonadism. Front Horm Res 39, 133–141.
Shaw, N D, Butler, J P, McKinney, S M, Nelson, S A, Ellenbogen, J M & Hall, J E. (2012). Insights into puberty: the relationship between sleep stages and pulsatile LH secretion. J Clin Endocr Metab 97, E2055–E2062.
Silveira, L F G & Latronico, A C. (2013). Approach to the patient with hypogonadotropic hypogonadism. J Clin Endocr Metab 98, 1781–1788.
Silveira, L G, Latronico, A C & Seminara, S B. (2013). Kisspeptin and clinical disorders. Adv Exp Med Biol 784, 187–199.
Skinner, D C, Albertson, A J, Navratil, A et al. (2009). Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis. J Neuroendocr 21, 282–292.
Skorupskaite, K, George, J T & Anderson, R A. (2014). The kisspeptin–GnRH pathway in human reproductive health and disease. Human Reprod Update 20, 485–500.
Skorupskaite, K, George, J T, Veldhuis, J D & Anderson, R A. (2018a). Neurokinin B regulates gonadotropin secretion, ovarian follicle growth, and the timing of ovulation in healthy women. J Clin Endocr Metab 103, 95–104.
Skorupskaite, K, George, J T, Veldhuis, J D, Millar, R P & Anderson, R A. (2018b). Neurokinin 3 receptor antagonism reveals roles for neurokinin B in the regulation of gonadotropin secretion and hot flashes in postmenopausal women. Neuroendocr 106, 148–157.
Skrapits, K, Kanti, V, Savanyú, Z et al. (2015). Lateral hypothalamic orexin and melanin-concentrating hormone neurons provide direct input to gonadotropin-releasing hormone neurons in the human. Fronts Cellular Neurosci 9, 1–13.
Southworth, M B, Matsumoto, A M, Gross, K M, Soules, M R & Bremner, W J. (1991). The importance of signal pattern in the transmission of endocrine information: pituitary gonadotropin responses to continuous and pulsatile gonadotropin-releasing hormone. J Clin Endocr Metab 72, 1286–1289.
Stamou, M I, Cox, K H & Crowley, W F Jr. (2015). Discovering genes essential to the hypothalamic regulation of human reproduction using a human disease model: adjusting to life in the “-omics” era. Endocr Revs 36, 603–621.
Stamou, M I & Georgopoulos, N A. (2017). Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism. Metab 86, 124–134.
Taziaux, M, Staphorsius, A S, Ghatei, M A, Bloom, S R, Swaab, D F & Bakker, J. (2016). Kisspeptin expression in the human infundibular nucleus in relation to sex, gender identity, and sexual orientation. J Clin Endocr Metab 101, 2380–2389.
Teles, M, Bianco, S D, Brito, V N et al. (2008). A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 358, 709–715.
Tenhola, H, Sinclair, D, Alho, H & Lahti, T. (2012). Effect of opioid antagonists on sex hormone secretion. J Endocr Invest 35, 227–230.
Teoh, S K, Mendelson, J H, Mello, N K & Skupny, A. (1988). Alcohol effects on naltrexone-induced stimulation of pituitary, adrenal, and gonadal hormones during the early follicular phase of the menstrual cycle. J Clin Endocr Metab 66, 1181–1186.
Thomsen, L & Humaidan, P. (2015). Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin. Curr Opin Obst Gynecol 27, 210–214.
Valdes-Socin, H, Almanza, M R, Fernández-Ladreda, M T, Debray, F G, Bours, V & Beckers, A. (2014). Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes. Fronts Endocr 5, 1–8.
Vuong, C, Van Uum, S H M, O’Dell, L E, Lutfy, K & Friedman, T C. (2010). The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Revs 31, 98–132.
Wahab, F, Atika, B, Shahab, M & Behr, R. (2016). Kisspeptin signalling in the physiology and pathophysiology of the urogenital system. Nat Revs Urol 13, 21–32.
Wildt, L, Leyendecker, G, Sir-Petermann, T & Waibel-Treber, S. (1993). Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy. Human Reprod 8, 350–358.
Wilkinson, M & Brown, R E. (2015). An Introduction to Neuroendocrinology, 2nd Edition (Cambridge: Cambridge University Press).
Williams, C L, Nishihara, M, Thalabard, J C et al. (1990). Duration and frequency of multiunit electrical activity associated with the hypothalamic gonadotropin releasing hormone pulse generator in the rhesus monkey: differential effects of morphine. Neuroendocr 52, 225–228.
Zatelli, M C, Ambrosio, M R, Bondanelli, M & degli Uberti, E. (2014). Pituitary side effects of old and new drugs. J Endocr Invest 37, 917–923.